Literature DB >> 27648015

Brain Natriuretic Peptide and Body Fluid Composition in Patients with Chronic Kidney Disease: A Cross-Sectional Study to Evaluate the Relationship between Volume Overload and Malnutrition.

Yasushi Ohashi1, Akinobu Saito2, Keisuke Yamazaki1, Reibin Tai2, Tatsuru Matsukiyo2, Atsushi Aikawa2, Ken Sakai2.   

Abstract

BACKGROUND/AIM: Fluid volume overload occurs in chronic kidney disease (CKD), leading to the compensatory release of natriuretic peptides. However, the elevated cardiac peptides may also be associated with malnutrition as well as volume overload.
METHODS: Body fluid composition was measured in 147 patients with CKD between 2009 and 2015, and its relationship to brain natriuretic peptide (BNP) levels was examined. Body fluid composition was separated into three components: (a) a water-free mass consisting of muscle, fat, and minerals; (b) intracellular water (ICW) content, and (c) extracellular water (ECW) content. Excess fluid mass was calculated using Chamney's formula.
RESULTS: The measured BNP levels in the tertile groups were 10.9 ± 5.4, 36.3 ± 12.5, and 393 ± 542 pg/ml, respectively. Patients in a higher log-transformed BNP level tertile were more likely to be older, to have a higher frequency of cardiac comorbidities, pulse pressure, C-reactive protein levels, and proteinuria, and to have lower serum sodium, kidney function, and serum albumin (p < 0.05). In body fluid composition, decreased body mass was significantly associated with the ECW-to-ICW ratio in relation to the downward ICW slope (r = -0.235, p = 0.004) and was strongly correlated with excess fluid mass (r = -0.701, p < 0.001). The ECW-to-ICW ratio and excess fluid mass was independently associated with the BNP levels.
CONCLUSION: Fluid volume imbalance between intra- and extracellular water regulated by decreased cell mass was independently associated with BNP levels, which may explain the reserve capacity for fluid accumulation in patients with CKD.

Entities:  

Keywords:  Bioimpedance analysis; Brain natriuretic peptide; Chronic kidney disease; Fluid overload; Malnutrition

Year:  2016        PMID: 27648015      PMCID: PMC5020383          DOI: 10.1159/000447024

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  25 in total

1.  Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

Authors:  Sandeep R Das; Mark H Drazner; Daniel L Dries; Gloria L Vega; Harold G Stanek; Shuaib M Abdullah; Russell M Canham; Anne K Chung; David Leonard; Frank H Wians; James A de Lemos
Journal:  Circulation       Date:  2005-10-04       Impact factor: 29.690

2.  Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients.

Authors:  Olivier Bouillanne; Gilles Morineau; Claire Dupont; Isabelle Coulombel; Jean-Pierre Vincent; Ioannis Nicolis; Simone Benazeth; Luc Cynober; Christian Aussel
Journal:  Am J Clin Nutr       Date:  2005-10       Impact factor: 7.045

3.  Is extracellular volume expansion of peritoneal dialysis patients associated with greater urine output?

Authors:  Andrew Davenport; Rabya Hussain Sayed; Stanley Fan
Journal:  Blood Purif       Date:  2011-08-09       Impact factor: 2.614

4.  N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.

Authors:  Qunying Guo; Peter Bárány; Abdul Rashid Qureshi; Sunna Snaedal; Olof Heimburger; Peter Stenvinkel; Bengt Lindholm; Jonas Axelsson
Journal:  Am J Nephrol       Date:  2008-12-12       Impact factor: 3.754

5.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

6.  Clinical significance of multi-frequency bioimpedance spectroscopy in peritoneal dialysis patients: independent predictor of patient survival.

Authors:  Emma L O'Lone; Annemarie Visser; Hazel Finney; Stanley L Fan
Journal:  Nephrol Dial Transplant       Date:  2014-03-05       Impact factor: 5.992

7.  Volume estimation in dialysis patients: the concordance of brain-type natriuretic peptide measurements and bioimpedance values.

Authors:  Mihály Tapolyai; Mária Faludi; Virág Réti; Zsolt Lengvárszky; Tibor Szarvas; Tibor Fülöp; Gabriella Bekő; Klára Berta
Journal:  Hemodial Int       Date:  2013-01-30       Impact factor: 1.812

8.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Chapter 3: Management of progression and complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01
View more
  6 in total

1.  Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients.

Authors:  Charles Chazot; Margaux Rozes; Cyril Vo-Van; Patrik Deleaval; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Eric Zaoui; Guillaume Jean
Journal:  Cardiorenal Med       Date:  2017-04-29       Impact factor: 2.041

2.  Association between Low Dietary Protein Intake and Geriatric Nutrition Risk Index in Patients with Chronic Kidney Disease: A Retrospective Single-Center Cohort Study.

Authors:  Aki Kiuchi; Yasushi Ohashi; Reibin Tai; Toshiyuki Aoki; Sonoo Mizuiri; Toyoko Ogura; Atsushi Aikawa; Ken Sakai
Journal:  Nutrients       Date:  2016-10-23       Impact factor: 5.717

3.  The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.

Authors:  Yi-Chun Tsai; Hui-Ju Tsai; Chee-Siong Lee; Yi-Wen Chiu; Hung-Tien Kuo; Su-Chu Lee; Tzu-Hui Chen; Mei-Chuan Kuo
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

4.  Brain natriuretic peptide reflects individual variation in hydration status in hemodialysis patients.

Authors:  Jenny Stenberg; Jan Melin; Magnus Lindberg; Hans Furuland
Journal:  Hemodial Int       Date:  2019-03-07       Impact factor: 1.812

5.  B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients.

Authors:  Nina Fang; Miaolin Che; Ling Shi; Zanzhe Yu; Zhaohui Ni; Wei Fang; Huihua Pang; Leyi Gu; Xinghui Lin
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

6.  Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial.

Authors:  Fabio Solis-Jimenez; Lucia Monserrat Perez-Navarro; Ricardo Cabrera-Barron; Jesus Antonio Chida-Romero; Geovana Martin-Alemañy; Edgar Dehesa-López; Magdalena Madero; Rafael Valdez-Ortiz
Journal:  BMC Nephrol       Date:  2022-09-20       Impact factor: 2.585

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.